We next investigated the expression of CCN3 mRNA in hONS cells derived from unrelated sporadic cases and controls to validate observations from microarray data (16), which suggested that CCN3 was decreased by 7.3% in PD patients (p <0.01; Figure 3). The gene discussed is CCN3; the disease is Parkinson disease.